Moderna
MRNA
#1218
Rank
NZ$32.46 B
Marketcap
NZ$81.82
Share price
-8.04%
Change (1 day)
88.71%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$32.46 Billion

As of June 2026 Moderna has a market cap of NZ$32.46 Billion. This makes Moderna the world's 1218th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$32.46 B54.23%
2025NZ$21.04 B-23.13%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Jun 5th, 2026 the market cap of Moderna was reported to be:

NZ$32.46 Billion
by Nasdaq info icon info icon
NZ$32.46 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$966.39 B 2,876.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$490.86 B 1,411.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$514.52 B 1,484.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$0.97 B-97.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.13 B-84.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.43 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$69.78 B 114.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$17.75 B-45.31%๐Ÿ‡บ๐Ÿ‡ธ USA